Dr. Timothy Donahue, Director of the UCLA Agi Hirshberg Center for Pancreatic Diseases and Garry Shandling Chair in Pancreatic Surgery at David Geffen School of Medicine at UCLA, has joined […]
An Overview of the Updates to the NCCN Guidelines for Pancreatic Cancer
The National Comprehensive Cancer Network (NCCN) works to improve cancer care through their vast collection of Guidelines for Patients. The latest version of the Guidelines for Patients: Pancreatic Cancer, sponsored […]
The 2022 UCLA Activity Summary Report
The UCLA Agi Hirshberg Center for Pancreatic Diseases continues to be one of the nation’s leading institutions for pancreatic cancer research, diagnosis, and treatment thanks to funding from the Hirshberg […]
Exciting Changes to the Hirshberg Center for Pancreatic Diseases
We are seeing the seeds we planted 25 years ago with the creation of the Foundation come to full bloom. A pillar of our Foundation mission was “to create premier […]
Research Publications from the Sahin-Toth Laboratory in 2022
The most recent addition to our laboratories at UCLA, the Sahin-Toth Laboratory focuses on hereditary chronic pancreatitis, a major risk factor for pancreatic cancer. Dr. Miklos Sahin-Toth joined UCLA to […]
Research Publications from the Hirshberg Translation Laboratory in 2022
This February marks 25 years since the creation of the Ronald S. Hirshberg Translational Pancreatic Cancer Research Laboratory. A cornerstone of our research program, this lab was the first at […]